Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | TINF2 |
| Upstream (Parents) |
|---|
| (<<) BCL2L1 → TINF2 |
| (<<) CENPF → TINF2 |
| (<<) CYB5R3 → TINF2 |
| (<<) GNAI2 → TINF2 |
| (<<) GNG5 → TINF2 |
| (<<) IFITM3 → TINF2 |
| (<<) JAK1 → TINF2 |
| (<<) LRP6 → TINF2 |
| (<<) MAP3K12 → TINF2 |
| (<<) MYL7 → TINF2 |
| (<<) PRKCD → TINF2 |
| (<<) PTAFR → TINF2 |
| (<<) PTMA → TINF2 |
| (<<) RAB5C → TINF2 |
| (<<) RAC2 → TINF2 |
| (<<) RHOA → TINF2 |
| (<<) RRAS → TINF2 |
| (<<) TGFB1 → TINF2 |
| (<<) TPP1 → TINF2 |
| (<<) ZFP36 → TINF2 |
| Downstream (Children) |
|---|
| TINF2 → ARHGEF4 (>>) |
| TINF2 → FUT1 (>>) |
| TINF2 → FZD8 (>>) |
| TINF2 → GLRX (>>) |
| TINF2 → HDAC4 (>>) |
| TINF2 → KLF4 (>>) |
| TINF2 → MAP3K4 (>>) |
| TINF2 → MAPK8 (>>) |
| TINF2 → MYO10 (>>) |
| TINF2 → PARD6G (>>) |
| TINF2 → PCK2 (>>) |
| TINF2 → RHOG (>>) |
| TINF2 → RNASE4 (>>) |
| TINF2 → SH3TC1 (>>) |
| TINF2 → SMAD2 (>>) |
| TINF2 → TAF9 (>>) |
